Канада - английски - Health Canada

baxter corporation - dextrose; sodium chloride; sodium lactate; calcium chloride; magnesium chloride - solution - 4.25g; 567mg; 392mg; 23.9mg; 15.2mg - dextrose 4.25g; sodium chloride 567mg; sodium lactate 392mg; calcium chloride 23.9mg; magnesium chloride 15.2mg - hemodialysis solution

Канада - английски - Health Canada

baxter corporation - dextrose; sodium chloride; sodium lactate; calcium chloride; magnesium chloride - solution - 1.5g; 567mg; 392mg; 23.9mg; 15.2mg - dextrose 1.5g; sodium chloride 567mg; sodium lactate 392mg; calcium chloride 23.9mg; magnesium chloride 15.2mg - hemodialysis solution

Канада - английски - Health Canada

baxter corporation - dextrose; sodium chloride; sodium lactate; calcium chloride; magnesium chloride - solution - 500mg; 567mg; 392mg; 23.9mg; 15.2mg - dextrose 500mg; sodium chloride 567mg; sodium lactate 392mg; calcium chloride 23.9mg; magnesium chloride 15.2mg - hemodialysis solution

САЩ - английски - NLM (National Library of Medicine)

gambro renal products - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - - calcium chloride 0.139 g in 1 l - there is no known contraindication to the use of prismasol solution. pregnancy category c. prismasol solution is a replacement solution of electrolytes, bicarbonate and dextrose and is pharmacologically inactive. animal reproduction studies have not been conducted with prismasol solution. while there are no adequate and well controlled studies in pregnant women, appropriate administration of prismasol solution with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to cause fetal harm, or affect reproductive capacity. maintenance of normal acid-base balance is important for fetal well being. prismasol solution is a replacement solution of electrolytes, bicarbonate and dextrose and is pharmacologically inactive. the components of prismasol solution are excreted in human milk. appropriate administration of prismasol solution with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to harm a nursing infant. safety and effectiveness have been established

САЩ - английски - NLM (National Library of Medicine)

fresenius medical care north america - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698) - dextrose monohydrate 1.5 g in 100 ml - delflex® peritoneal dialysis solutions are indicated in the treatment of chronic renal failure patients being maintained on peritoneal dialysis when nondialytic medical therapy is judged to be inadequate. none known.

САЩ - английски - NLM (National Library of Medicine)

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid, unspecified form - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), potassium phosphate, monobasic (unii: 4j9fj0hl51) (potassium cation - unii:295o53k152, phosph - dextrose monohydrate 5 g in 100 ml - ionosol mb and 5% dextrose injection is indicated for intravenous administration to infants for treatment of dehydration, acidosis, diarrhea, and burns, but only after administration of an initial priming solution: 15 ml of 5% dextrose and 0.45% sodium chloride injection/kg of body weight. in adults, ionosol mb and 5% dextrose injection is indicated postoperatively for intravenous fluid and electrolyte maintenance therapy, with a small amount of carbohydrate calories for reducing catabolism of endogenous protein reserves. solutions containing potassium are contraindicated in diseases where high potassium levels may be encountered.

Канада - английски - Health Canada

abbott laboratories, limited - calcium chloride; magnesium chloride; dextrose; sodium chloride; sodium lactate - liquid - .184mg; .051mg; 42.5mg; 5.38mg; 4.48mg - calcium chloride .184mg; magnesium chloride .051mg; dextrose 42.5mg; sodium chloride 5.38mg; sodium lactate 4.48mg - hemodialysis solution

Канада - английски - Health Canada

abbott laboratories, limited - dextrose; sodium lactate; sodium chloride; calcium chloride; magnesium chloride - solution - 25mg; 3.92mg; 5.62mg; 0.26mg; 0.15mg - dextrose 25mg; sodium lactate 3.92mg; sodium chloride 5.62mg; calcium chloride 0.26mg; magnesium chloride 0.15mg - irrigating solutions

САЩ - английски - NLM (National Library of Medicine)

baxter healthcare corporation - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), lactic acid, unspecified form (unii: 33x04xa5at) (lactic acid, unspecified form - unii:33x04xa5at), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37, bicarbonate ion - unii:hn1zra3q20) - calcium chloride 0.184 g in 1 l - prismasol and phoxillum solutions are indicated in pediatric and adult patients for use as a replacement solution in continuous renal replacement therapy (crrt) to replace plasma volume removed by ultrafiltration and to correct electrolyte and acid-base imbalances. they may also be used in case of drug poisoning when crrt is used to remove dialyzable substances. phoxillum and prismasol replacement solutions are contraindicated in patients with known hypersensitivities to these products. prismasol and phoxillum are pharmacologically inactive solutions. while there are no adequate and well controlled studies in pregnant women, appropriate administration of prismasol and phoxillum solutions with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to cause fetal harm. animal reproduction studies have not been conducted with prismasol and phoxillum solutions. the estimated background risk of major birth defects and miscarriage for the indicated population are unknown. all pregnancies have a background risk of birth defect, loss or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. maintenance of normal acid-base balance is important for fetal well-being. the components of prismasol and phoxillum solutions are excreted in human milk. appropriate administration of prismasol and phoxillum solutions with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to harm a nursing infant. safety and effectiveness have been established based on published clinical data of crrt replacement solutions with compositions similar to prismasol and phoxillum used in adults and two hemofiltration studies in pediatric patients, including a study of newborns to 17 years old. the experience with prismasol and phoxillum solutions in geriatric patients has not identified novel concerns.

САЩ - английски - NLM (National Library of Medicine)

american regent, inc. - calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - calcium chloride 100 mg in 1 ml - calcium chloride is indicated in the immediate treatment of hypocalcemic tetany.  other therapy, such as parathyroid hormone or vitamin d, may be indicated according to the etiology of the tetany. it is also important to institute oral calcium therapy as soon as practicable. calcium salts have been used as adjunctive therapy in a number of conditions, including the following: - insect bites or stings, such as black widow spider bites. sensitivity reactions, particularly when characterized by urticaria. as an aid in the treatment of depression due to overdosage of magnesium sulfate. as an aid in the management of the acute symptoms in lead colic. in cardiac resuscitation, particularly after open heart surgery, calcium chloride has been used when epinephrine has failed to improve weak or ineffective myocardial contractions. insect bites or stings, such as black widow spider bites. sensitivity reactions, particularly when characterized by urticaria. as an aid in the treatment of depression due to overdo